Consumer Prices Unchanged, Dow Rises

March 18, 2010 9:59 AM |
Consumer prices held steady in February signalling that the economy is on a slow mend. The Dow rose 27 points to 10,761 while Nasdaq edged down a fraction to 2388.

 

On the upside

The Food and Drug Administration approved Somaxon Pharmaceuticals' (Nasdaq: SOMX) insomnia treatment Silenor.

Finisar (Nasdaq: FNSR) increased its public offering to more than 8.6 million shares priced at $14 per share.

Borders (NYSE: BGP) announced an agreement with gift registry solutions company MarCole Interactive Systems as the exclusive book retailer for the new National Teacher Registry.

On the downside

First quarter earnings for CRA International (Nasdaq: CRAI) plunged to fall far short of estimates as revenue dropped and the company announced the elimination of 47 positions.

SunTrust Robinson Humphrey analyst Jennifer Demba downgraded Synovus Financial (NYSE: SNV).

While Winnebago (NYSE: WGO) swung to a second quarter profit, the company filed a registration statement to sell $35 million worth of common shares.

In the broad market, declining issues outpaced advancers by a margin of more than 3 to 2 on the NYSE and by more than 9 to 7 on Nasdaq. The Russell 2000 which tracks small cap stocks slipped a point to 682.

Tags:

Search


About this Entry

This page contains a single entry by published on March 18, 2010 9:59 AM.

Markets Open Mixed As Jobless Claims Slip Less Than Expected was the previous entry in this blog.

Tame Inflation Lifts Markets To Higher Close is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12